Four reporting parties list the same shared stake in Quoin Pharmaceuticals (QNRX).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
An amended ownership disclosure for Quoin Pharmaceuticals (QNRX) reveals that Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each report beneficial ownership of 8,396,903 ordinary shares, representing 4.99% of the class. This stake is a shared position, not four separate holdings, with shared voting and dispositive power.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.